A Controlled Trial of Itraconazole to Prevent Relapse of<i>Penicillium marneffei</i>Infection in Patients Infected with the Human Immunodeficiency Virus

Abstract

In patients infected with HIV who have completed successful primary treatment of P. marneffei infection, secondary prophylaxis with oral itraconazole is well tolerated and prevents relapses of this opportunistic infection.